Icon

INSYS Therapeutics, Inc Stock Analysis and Price Target COMMON STOCK | Other | NSD

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis

USD 0.29

0.00 (0.00)%

USD 4,995,459.82B

N/A

N/A

N/A

Icon

INSY

INSYS Therapeutics, Inc (USD)
COMMON STOCK | NSD
USD 0.29
0.00 0

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis

USD 4,995,459.82B

N/A

USD 0.29

INSYS Therapeutics, Inc Stock Forecast

N/A

Based on the INSYS Therapeutics, Inc stock forecasts from 0 analysts, the average analyst target price for INSYS Therapeutics, Inc is not available over the next 12 months. INSYS Therapeutics, Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of INSYS Therapeutics, Inc is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, INSYS Therapeutics, Inc’s stock price was USD 0.29. INSYS Therapeutics, Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for INSYS Therapeutics, Inc
No recent average analyst rating found for INSYS Therapeutics, Inc

Company Overview

Insys Therapeutics, Inc., a specialty pharmaceutical company, focuses on cannabinoids and drug delivery systems that address unmet patient needs. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, a...Read More

http://www.insysrx.com

1333 South Spectrum Boulevard, Chandler, AZ, United States, 85286

226

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To INSYS Therapeutics, Inc (Sector: Other )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LGCY
Legacy Reserves Inc 0.00 (0.00%) USD61,525,874.67B 1.10 5.30

ETFs Containing INSY

Symbol Name Weight Mer Price(Change) Market Cap
no data

Frequently Asked Questions About INSY Stock

Stock Target Advisor's fundamental analysis for INSYS Therapeutics, Inc's stock is Very Bearish.

Unfortunately we do not have enough data on INSY's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on INSY's stock to indicate what its average analyst target is.

INSY stock's Price/Earning ratio is 115.90. Based on this INSY may be a overvalued for its sector.

The last closing price of INSY's stock was USD 0.29.

The most recent market capitalization for INSY is USD 4,995,459.82B.

Unfortunately we do not have enough analyst data on INSY's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...